The Foundation Fighting Blindness was established in 1971 by a passionate group of families driven to find treatments and cures for inherited retinal diseases that were affecting their loved ones. At that time, little was known about these blinding retinal diseases. Very little research was being done, and there were no clinical trials for potential treatments. The Foundation’s goal was clear and focused; to drive the research that would lead to preventions, treatments and cures for blinding retinal diseases, including age-related macular degeneration, retinitis pigmentosa, Usher syndrome, Stargardt disease and Leber congenital amaurosis (LCA). Together these conditions affect more than ten million Americans and millions more throughout the world. Today, the Foundation Fighting Blindness is the world’s leading private funder of retinal disease research. That funding has been a driving force behind the progress toward cures, including the identification of more than 270 genes linked to retinal disease, and the launch of over forty clinical trials for potential treatments. On an annual basis, the Foundation Fighting Blindness funds more than ninety-three research grants. The research projects are conducted by more than ninety-six research investigators at 71 institutions, eye hospitals and universities in the United States. The Foundation funding extends internationally to laboratories in Australia, Belgium, Brazil, Canada, Denmark, England, Finland, France, Germany, Israel, Italy, Mexico, the Netherlands, Poland and Switzerland.